Brussels Metropolitan Area
Associate Director, Candidate Program Manager, Early Phase Drug Development - Gene Therapy & Immunology
A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader - we’re focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions. A healthier and fairer future requires collective action and we believe in extending our impact beyond what we can achieve alone. We work closely and forge strong connections with diverse networks of patients, caregivers, health care professionals and other stakeholders who know the challenges of severe diseases.
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
UCB – Inspired by patients. Driven by science.
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 7500 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 20% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules and no major patent expiration in the next decade; - 23% of 2017 revenue reinvested into Research & Development - 2017 Key Financials: €4.5 billion global revenue Specialties: Neurology, Immunology
Delivery Manager for EHS CAPEX Service Contract
Altran is the global leader in innovation and high-tech engineering consulting. Business Unit Operational Excellence, Supply Chain & Innovation: Guide companies to achieve Operational Excellence. Increasing Efficiency or Quality, Reducing Costs or Lead Time. Innovative R&D projects or Technology Roadmapping, Engineering Investment Projects.